**Core Concept**
The use of oral contraceptives has been associated with a complex interplay of hormonal and physiological changes that can influence cancer risk. Specifically, the estrogen and progesterone components of oral contraceptives can affect breast tissue, potentially altering the risk of breast cancer.

**Why the Correct Answer is Right**
The increased risk of breast cancer with oral contraceptive use is thought to be related to the hormonal stimulation of breast tissue by estrogen and progesterone. This can lead to an increased proliferation of breast cells, which may result in the formation of malignant tumors. The risk of breast cancer is higher in women who start using oral contraceptives at a younger age and who use them for longer periods. Additionally, the risk may be influenced by the type of progesterone used in the oral contraceptive.

**Why Each Wrong Option is Incorrect**
* **Option A:** Colon cancer is actually associated with a reduced risk in women who use oral contraceptives, particularly those who have used them for an extended period. This is thought to be due to the protective effects of estrogen on the colon.
* **Option B:** Ovarian cancer is actually associated with a reduced risk in women who use oral contraceptives. This is thought to be due to the suppression of ovulation and the resulting reduction in estrogen levels, which can reduce the risk of ovarian cancer.
* **Option D:** This option is incorrect because not all of the above options are associated with an increased risk of cancer with oral contraceptive use.

**Clinical Pearl / High-Yield Fact**
It's worth noting that the increased risk of breast cancer with oral contraceptive use is generally small and transient, returning to baseline within a few years after stopping the medication.

**✓ Correct Answer: C. Breast**